Onex to Announce Fourth Quarter and Full Year 2023 Results on February 23, 2024
January 31, 2024 09:00 ET
|
ONEX Corporation
All amounts in U.S. dollars unless otherwise stated TORONTO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Onex Corporation (TSX: ONEX) will release its results for the fourth quarter and full year ended...
Radware Schedules Conference Call for Its Fourth Quarter and Full Year 2023 Earnings
January 03, 2024 06:00 ET
|
Radware Ltd.
TEL AVIV, Israel, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR), a leading provider of cyber security and application delivery solutions, will announce its fourth quarter and full year...
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
March 20, 2023 16:05 ET
|
Exagen Inc.
SAN DIEGO, March 20, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year...
Legacy Housing Corporation Reports Full Year 2022 Financial Results
March 15, 2023 17:19 ET
|
Legacy Housing Corporation
BEDFORD, Texas, March 15, 2023 (GLOBE NEWSWIRE) -- Legacy Housing Corporation (the "Company” or “Legacy", NASDAQ: LEGH) today announced its financial results for the full year end December 31, 2022....
Cingulate Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business Update
March 10, 2023 16:05 ET
|
Cingulate Inc.
CTx-1301 Phase 3 Adult Dose-Optimization Study Ongoing; Results Expected 3Q 2023 Positive Top-Line Data from CTx-1301 Fed/Fast Study Announced, Full Results Submitted for Presentation at Forthcoming...
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
March 06, 2023 16:05 ET
|
Exagen Inc.
SAN DIEGO, March 06, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter and year ended December...
Immuneering Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
March 06, 2023 16:05 ET
|
Immuneering Corporation
First patient dosed in Phase 1/2a clinical trial of IMM-1-104 in advanced solid tumors with any RAS mutation Provides debut guidance for IMM-1-104 program: initial Phase 1 PK and safety data expected...
Codere Online Reports Financial Results for the Fourth Quarter and Full Year 2022
February 28, 2023 07:30 ET
|
Codere Online Luxembourg, S.A.
Total revenue was €35.6 mm in Q4 2022, while net gaming revenue was €37.7 mm in the period, in both cases 70% above Q4 20211. 2022 net gaming revenue reached €122.9 mm, 48% above 2021.Mexico...
Onex Reports Fiscal 2022 Results
February 24, 2023 07:00 ET
|
ONEX Corporation
All amounts in U.S. dollars unless otherwise stated TORONTO, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Onex Corporation (TSX: ONEX) today announced its financial results for the fourth quarter and year...
Rackspace Technology Reports Fourth Quarter and Full Year 2022 Results
February 22, 2023 16:10 ET
|
Rackspace Technology, Inc.
Fourth Quarter Revenue of $787 million, up 1% Year-over-Year; 2022 Revenue of $3,122 million, up 4% Year-over-YearFourth Quarter Core Revenue of $752 million, up 2% Year-over-Year; 2022 Core Revenue...